Results 61 to 70 of about 73,761 (291)

Effects of an Organic Acid Blend on Growth Performance, Redox Homeostasis, and Intestinal Microbiota of Broilers in an Antibiotic‐Free Production System Under Winter Environmental Challenges

Animal Research and One Health, EarlyView.
Schematic summary of the effects of organic acids on growth performance and gut health‐related parameters in broilers. ABSTRACT This study was conducted to evaluate the effects of an organic acid blend on growth performance, redox homeostasis, and intestinal microbiota of broilers raised in an antibiotic‐free system during the winter season in China ...
Rong‐Hui Huang, Hong‐Lin Li, Yu Zhang, Jie Wang, Shao‐Qing Wang, Xue‐Wu Li, Lane Pineda, Xiang‐Dong Kuang, Giseli Heim, Mahmoud Mohamed Khalil, Lv‐Hui Sun, Zhang‐Chao Deng   +11 more
wiley   +1 more source

The specifics of antibiotic therapy in children with acute intestinal infections

Медицинский совет, 2016
The article discusses indications for antibiotic treatment and choice of drugs in children with acute enteric infections. Our study demonstrated the efficacy and safety of cefixime, the oral third-generation cephalosporin.
T. A. Ruzhentsova, A. A. Ploskireva, L. N. Milyutina, A. V. Gorelov   +3 more
doaj   +1 more source

Thrombocytopenia Possibly Caused by Structurally Related Third-Generation Cephalosporins [PDF]

, 1991
Thrombocytopenia is defined as a decrease in the platelet count to <100 × 109/L and it is the most commonly reported drug-induced blood dyscrasia. Heparin is the most commonly reported cause of drug-induced thrombocytopenia with a reported incidence ...
Robert Lee Hull, Donald Brandon
core   +1 more source

Consumption of cephalosporins in the community, European Union/European Economic Area, 1997-2017 [PDF]

, 2021
Contains fulltext : 238517.pdf (Publisher’s version ) (Open Access)OBJECTIVES: Data on cephalosporin consumption in the community were collected from 30 EU/EEA countries over two decades.
Goossens, H., Bruyndonckx, R., Natsch, S.S., Hens, Niel, Monnet, Dominique L., Goossens Herman, Weist, Klaus, Molenberghs, Geert, Versporten, A., Molenberghs Geert, Versporten, Ann, Matuz Mária, Monnet Dominique L., Monnet, D.L., Molenberghs, G., Adriaenssens, Niels, Weist, K., Hens Niel, Coenen, S., Bruyndonckx Robin, Adriaenssens Niels, Coenen, Samuel, Coenen Samuel, Goossens, Herman, Versporten Ann, Bruyndonckx, Robin, Weist Klaus, Hens, N., Adriaenssens, N.   +28 more
core   +1 more source

Applying machine learning to pharmacovigilance data: A proof‐of‐concept study

British Journal of Clinical Pharmacology, EarlyView.
Aim Machine learning (ML) applications in pharmacovigilance remain limited and underexplored. Using data from the French National pharmacovigilance database (FNPV), this proof‐of‐concept study aimed to assess the feasibility of using a ML algorithm—eXtreme Gradient Boosting (XGBoost)—combined with SHapley Additive exPlanations (SHAP) analysis, to ...
Romain Barus, Pauline Schiro, Jean‐Luc Faillie, Romane Freppel, Johana Béné, Claire de Canecaude, François Montastruc   +6 more
wiley   +1 more source

Oral cephalosporins in the ent-practice

Медицинский совет, 2018
The article presents modern data on antibacterial therapy for acute infectious and inflammatory diseases of the upper respiratory tract and ear, provides a overview of the most commonly used antibiotics in the practice of ENT, as well as clinical studies
S. V. Morozova, M. V. Svistushkin
doaj   +1 more source

Ceftriaxone‐induced liver injury: Incidence, phenotypic characterization and predictive factors

British Journal of Clinical Pharmacology, EarlyView.
Introduction Ceftriaxone is a widely used third‐generation cephalosporin in hospitalized patients. Although generally considered safe, it has been associated with hepatobiliary complications and emerging reports of drug‐induced liver injury (DILI). However, data on its true incidence, phenotypic patterns, and predictors remain limited. This study aimed
Mohamed Hatem, Mohannad N. AbuHaweeleh, Humam Emad Rajha, Mhd Osama Rahhal, Ahmad Hamdan, Lina Naseralallah   +5 more
wiley   +1 more source

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Abstract Irinotecan, a topoisomerase I inhibitor, is available as both non‐pegylated and pegylated formulations. The non‐pegylated formulation is licensed for use in advanced colorectal cancer either in combination with other agents or as monotherapy.
Dharmisha Chauhan, Cinzia Dello Russo, Jack Thompson, Dyfrig A. Hughes, Katherine Payne, Maria Tsakiroglou, Paul Ross, Rena Chauhan, Simon Jenkinson, Jessica Keen, Sophie Harding, Eleanor Lau, Michael Braun, Roshan Agarwal, Richard Adams, Elisabeth Rolf, Farah Al‐Sheikhli, Sarah Mitchell, Ruth Hammond, Rosie Roberts, Lorna Cairns, Shirley Heggarty, Janet Graham, Justin Mencel, Munir Pirmohamed   +24 more
wiley   +1 more source

Extended-spectrum beta-lactamases producing extensively drug-resistant Salmonella Typhi in Punjab, Pakistan

Journal of Infection in Developing Countries, 2020
Introduction: The multidrug-resistant (MDR) Salmonella enterica serovar Typhi isolates have been increasingly reported from the Asian and African countries.
Muhammad Saeed, Muhammad Hidayat Rasool, Farhan Rasheed, Muhammad Saqalein, Muhammad Atif Nisar, Ambreen Anwar Imran, Saba Tariq, Afreenish Amir, Aamer Ikram, Mohsin Khurshid   +9 more
doaj   +1 more source

Co-production of ESBL and AmpC β-Lactamases in Clinical Isolates of A. baumannii and A. lwoffii in a Tertiary Care Hospital From Northern India [PDF]

Journal of Clinical and Diagnostic Research, 2014
Background: Acinetobacter baumannii is an important cause of health care associated infections which are difficult to control and treat, because of widespread antimicrobial resistance which is possessed by this organism.
Pooja Singla, Rama Sikka, Antariksh Deeep, Deep Gagneja, Uma Chaudhary   +4 more
doaj   +1 more source